By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan Biovitrum 


  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a



Company News
Swedish Orphan Biovitrum - Orfadin Capsules Approved In The Kingdom Of Saudi Arabia For The Treatment Of Hereditary Tyrosinemia Type 1 5/17/2017 6:32:06 AM
Swedish Orphan Biovitrum Release: First Patients Enrolled In 24 Month Real-World Study Evaluating Effectiveness Of Elocta 1/19/2017 7:55:30 AM
Swedish Orphan Biovitrum: Elocta Approved in Kuwait For The Treatment Of Hemophilia A 11/21/2016 12:39:17 PM
Swedish Orphan Biovitrum: European Study Of Real-Life Hemophilia Treatment Emphasizes Need To Improve Standard Of Care 11/14/2016 12:07:06 PM
Swedish Orphan Biovitrum: Alprolix Approved In Switzerland For The Treatment Of Hemophilia B 10/28/2016 9:52:03 AM
Swedish Orphan Biovitrum: European Commission (EC) Grants SOBI003 Orphan Designation For The Treatment Of MPS IIIA 10/19/2016 11:30:26 AM
Swedish Orphan Biovitrum: Alprolix Obtains Reimbursement Across The United Kingdom 9/26/2016 10:23:19 AM
Swedish Orphan Biovitrum: Milan Zdravkovic Joins Sobi As Senior Vice President, Head Of Research & Development 9/26/2016 7:47:45 AM
Swedish Orphan Biovitrum: Elocta Obtains Reimbursement In UK, Italy And France, Complemented By Real-World Data And Extensive Patient Experience 9/21/2016 9:08:11 AM
Swedish Orphan Biovitrum’s CEO Divests A Portion Of Shares 8/9/2016 10:46:07 AM